Aria Pharmaceuticals Alternatives & Competitors
12 companies similar to Aria Pharmaceuticals — Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering a...
Companies similar to Aria Pharmaceuticals
Advenchen Laboratories, LLC
Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter...
Cantabio Pharmaceuticals, Inc.
Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative d...
R2M Pharma, Inc.
R2M is a collaborative pharmaceutical company that works with you throughout the discovery...
MEDIBIOFARMA SL
To make disease-modifying treatments available to patients with serious or life-threatenin...
Rival Readout
Competing with Aria Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Romark, L.C.
Positively impacting the lives of people worldwide
Satori Pharmaceuticals
Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative di...
Reborna Biosciences, Inc.
Save the life of rare disease patients and the parents by RNA binding molecules.
Nirogy Therapeutics
Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...
EOLO PHARMA
Cutting-Edge Pharmacological Treatment for Obesity
KBP Biosciences
At KBP we are consistently reminded that patient care is the end goal of what we do daily.
VG Life Sciences
Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through...
Oak Bay Biosciences, Inc.
Developing Next-Generation Therapies for Inherited Retinal Diseases
About Aria Pharmaceuticals
Aria Pharmaceuticals, founded in 2014, is a preclinical-stage pharmaceutical company based in the United States. The company specializes in the discovery and development of novel small molecule therapies, primarily targeting complex and hard-to-treat diseases. With a mission to accelerate drug discovery and increase su...
Pharmaceuticals, Drug Discovery, R&D, Preclinical-stage, Small Molecules, Novel Therapies, Complex Diseases, Hard-to-treat Diseases, Breakthrough Treatments, Therapeutic Areas, Disease Research, Medical Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Aria Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Aria Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.